Subscribe to Updates for A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®

Stay informed about the latest developments in this trial. By subscribing, you will receive updates directly to your email. These updates will provide you with important information regarding any changes or progress related to the trial.